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Vascular function of the peripheral and coronary
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In this issue of the journal, Scholtens et al1 report of
an absence of any correlation (r = 0.13, SEE = 54;
P = .36) between hyperemic myocardial and peripheral
blood flows during pharmacological vasodilation with
adenosine in a heterogenous group of patients and
healthy volunteers as determined with 13N-ammonia
PET. The study is unique in that it concurrently mea-
sured the blood flow increase or vasomotor response
during pharmacologically induced vasodilation of the
arteriolar resistance vessels in the myocardium and
upper limb muscle. The current investigation agrees
with earlier observations from Bottcher et al2 but
extends them now also to the same stimulus to induce
flow increases in the coronary and peripheral circulation.
Bottcher et al2 were first to describe that the peripheral
arterial flow responses to transient forearm ischemia did
not correlate with dipyridamole-induced hyperemic
myocardial blood flow increases. Thus, the current and
previous investigations2 strongly suggest different reg-
ulatory mechanisms of the coronary and peripheral
microcirculations in the diseased and normal vascular
states. Extrapolations between findings in the two vas-
cular beds therefore may not necessarily apply. At the
first sight, the results from Scholtens1 and those from
Bottcher et al2 may indeed contrast the reported asso-
ciation between vascular function of the brachial
and epicardial artery from a previous investigation
conducted by Anderson et al.3 In the latter study, the
stimuli to provoke the vasomotor response in the
peripheral and coronary circulation were different and a
different vascular bed was examined, i.e. conductance
arteries. Alterations of epicardial artery diameter in
response to intracoronary acetylcholine infusion were
determined with quantitative coronary angiography
(QCA), while the change in brachial artery diameter in
response to reactive hyperemia in the peripheral circu-
lation was determined with vascular ultrasound. Thus,
endothelial function of the epicardial artery was spe-
cifically tested with acetylcholine stimulation of the
muscarinergic receptor, whereas flow-mediated brachial
artery response was determined in response to hyper-
emic flow increases. In both the instances, the
endothelial vasoreactivity of the conduit vessels of the
periphery and coronary circulation was tested. This may
explain the observed statistically significant but rather
weak correlation between endothelium-dependent
vasomotor responses at the site of conduit vessel of the
peripheral and coronary circulation in patients with and
without angiographically determined CAD (P = .36,
P \ .01) (Figure 1)3. Interestingly, this weak correlation
appeared to be driven by patients without evidence of
structural CAD. Conceptually, if these patients without
evidence of structural CAD were taken out of the
analysis, no association between peripheral and coro-
nary endothelial function would probably exist. Thus,
the results from Anderson et al3 suggest that CAD-
related advanced structural alterations may actually
dissolve the described association of endothelial func-
tion between the peripheral and coronary circulation.
The prognostic value of the assessment of endo-
thelial or vascular dysfunction of the peripheral and
coronary circulation is well established.4-6 In particular,
the power of peripheral and coronary endothelial dys-
function in response to various stimuli in the prediction
of cardiovascular events appears to be comparable.5
Cardiovascular events therefore may occur remotely
from the site of endothelial dysfunction identified. These
observations strongly suggest a systemic nature of vas-
cular dysfunction and its central role in predicting future
cardiovascular events. Vascular dysfunction has been
appreciated as a useful integrating index of the overall
stress burden by various cardiovascular risk factors on
the arterial wall, taking into account the cumulative risk
of cardiovascular risk factors and as yet unknown vari-
ables and genetic predispositions.4,5,7 Despite this, it is
From the Department of Internal Medicine, Division of Cardiology,
Nuclear Cardiology,a University Hospitals of Geneva, Geneva,
Switzerland; and Department of Cardiology,b Cardiovascular Cen-
ter, University Hospital Zurich, Zurich, Switzerland.
Reprint requests: Thomas H. Schindler, MD, PhD, Department of
Internal Medicine, Division of Cardiology, Nuclear Cardiology,
University Hospitals of Geneva, 6th Floor, Rue Gabrielle-Perret-
Gentil 4, 1211 Geneva, Switzerland; thomas.schindler@hcuge.ch.
J Nucl Cardiol 2011;18:201–3.
1071-3581/$34.00
Copyright  2011 American Society of Nuclear Cardiology.
doi:10.1007/s12350-011-9357-0
201
important to keep in mind that forearm conduit and
resistance vessels do not develop atherosclerotic dis-
ease.7 Currently, no systematic investigations of both the
forearm and the coronary circulation have been per-
formed, and therefore the relation between vasomotor
function in the forearm and coronary circulation remains
poorly understood. In this direction, the observations
from Scholtens et al1 shed some new light in that they
did not observe an association between vasomotor
function of the resistance vessels in the periphery and
the coronary circulation when assessed concurrently
with adenosine-induced hyperemic flow increases.
Conversely, their study does not provide any mecha-
nistic insight about the mechanisms underlying the
vasoreactivity in the upper limb microcirculation in
response to adenosine stimulation. Intravenous adeno-
sine infusion caused a much lower flow increase in the
upper limb than in the myocardium, which may be
related to effectively lower adenosine arriving in the
peripheripheral circulation and, at least in part, different
mechanisms underlying peripheral vasoreactivity.1 As
regards the hyperemic myocardial blood flow increase
during pharmacologically induced vasodilation of the
arteriolar vessels, vascular smooth muscle-relaxing
substances like adenosine, dipyridamole, or, more
recently, adenosine receptor agonists decrease resistance
to flow at the site of the coronary arteriolar resistance
vessels and, thereby, cause a maximal or submaximal
hyperemic myocardial blood flow increase.8,9 The
resulting hyperemic coronary flow increase is consid-
ered to represent predominantly an endothelium-
independent flow response as the aforementioned sub-
stances increase hyperemic flow increases through
vascular smooth muscle cell relaxation at the site of the
coronary arteriolar vessels.8,10 Blocking the endothelial
nitric oxide synthase (eNOS) by intravenous infusion of
NG-monomethyl-L-arginine, however, results into a
significant loss of adenosine-induced MBF increases by
20%-25% as measured with PET.9,11,12 It may be con-
cluded that shear-sensitive components of the coronary
endothelium contribute in part through a flow-mediated
and, thus, nitric oxide-mediated coronary vasodilation to
the overall hyperemic MBF increase during pharmaco-
logic vasodilation.7,8,13 Such a myocardial flow response
has also been appreciated as total integrated coronary
circulatory function.8,9,14 The complexity of the mech-
anisms underlying hyperemic MBF increases during
pharmacologic vasodilation may also explain, at least in
part, the absence of any correlation between hyperemic
myocardial and peripheral blood flows during pharma-
cological vasodilation with adenosine as determined
with 13N-ammonia PET.1 Overall, the investigation by
Scholtens et al1 add further to the consideration that
vascular (dys)function in the peripheral and coronary
circulation may indeed reflect different features and
stages of vascular disease. Given that the forearm cir-
culation does not develop atherosclerotic disease,7
systemic comparative investigations of endothelial, or
circulatory dysfunction of both the forearm and the
coronary circulation and its response to pharmaceutical
intervention15-19 could possibly contribute to better
identify and characterize pathophysiological mecha-
nisms favoring the initiation and progression of the CAD
process and/or possible protective responses within the
arterial wall aiming to counterbalance the adverse
effects of various cardiovascular risk factors. Such
an emerging concept certainly deserves further
investigations.
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